<?xml version="1.0" encoding="UTF-8"?>
<records>
<record>
<language>eng</language>
<publisher>Science and Education Publishing</publisher>
<journalTitle>American Journal of Nanomaterials</journalTitle>
<eissn>2372-3122</eissn>
<publicationDate>2015-11-03</publicationDate>
<volume>3</volume>
<issue>2</issue>
<startPage>40</startPage>
<endPage>56</endPage>
<doi>10.12691/ajn-3-2-1</doi>
<publisherRecordId>AJN2015321</publisherRecordId>
<documentType>article</documentType>
<title language="eng">An integrated in Vitro and in Vivo Testing Approach to Assess Pulmonary Toxicity of Engineered Cadmium-Doped Silica Nanoparticles</title>
<authors>
<author>
<name>Uliana De Simone</name>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Elisa Roda</name>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Cinzia Signorini</name>
<affiliationId>2</affiliationId>
</author>
<author>
<name>Teresa Coccini</name>
<email>teresa.coccini@fsm.it</email>
<affiliationId>3</affiliationId>
</author>

</authors>
<affiliationsList>
<affiliationName affiliationId="1">Department of Clinical Surgical, Diagnostic and Pediatric Sciences, Faculty of Medicine and Surgery, University of Pavia, Pavia, Italy</affiliationName>

<affiliationName affiliationId="2">Department of Pathophysiology, Experimental Medicine, and Public Health, University of Siena, Siena, Italy</affiliationName>
<affiliationName affiliationId="3">Laboratory of Clinical and Experimental Toxicology, Toxicology Division, IRCCS Salvatore Maugeri Foundation, Scientific Institute of Pavia Medical Centre, Pavia, Italy</affiliationName>
</affiliationsList>
<abstract language="eng">An in vitro and in vivo testing strategy for assessing the pulmonary effects was used to investigate the safety characteristics of silica nanoparticles doped with cadmium (Cd-SiNPs). In A549 cells, Cd-SiNPs (0.5-100 μg/ml) caused (i) mitochondrial dysfunction and apoptosis at 1 ̦g/ml, (ii) GSH depletion at 10̦g/ml, (iii) membrane alterations at 25 ̦g/ml, after 1-day, and (iv) cell growth and proliferation inhibition at 0.05 ̦g/ml after prolonged exposure. Cd-SiNP effects were more pronounced compared to CdCl2. SiNPs affected GSH content only. In vivo results revealed early (1 day) and persistent (until 1 month) rat lung damage after intratracheal instillation of Cd-SiNPs (1mg/rat) in terms of enhanced apoptotic phenomena and altered lung parenchyma morphology. Cd-SiNPs and CdCl2 caused a delayed occurrence of oxidative stress by increasing SOD1, iNOS, and F2-IsoPs. The latter was preceded by marked increase of F2-IsoPs levels in plasma. SiNPs did not cause oxidative stress. Cd-SiNPs showed a higher reactivity than CdCl2 and SiNPs. In vitro and in vivo data on Cd-SiNP toxicity suggest that the lung is a susceptible target tissue. These findings support the concept that multiple assays and an integrated testing strategy should be recommended to characterize toxicological response to NPs.</abstract>
<fullTextUrl format="pdf">http://pubs.sciepub.com/ajn/3/2/1/ajn-3-2-1.pdf</fullTextUrl>
<keywords language="eng"><keyword>pulmonary</keyword>
<keyword>in vivo</keyword>
<keyword>in vitro</keyword>
<keyword>nanotoxicology</keyword>
<keyword>silica</keyword>
<keyword>cadmium</keyword>
</keywords>
</record>
</records>
